Infuse Bone Graft Claim Can’t Be Based On Sales Reps’ Prediction Of Approval

(August 25, 2015, 12:57 PM EDT) -- ST. LOUIS — Alleged statements by Medtronic Inc. sales representatives that an off-label use of its Infuse bone graft would be approved in the future is an opinion and not a...

To view the full article, register now.